Related Experiment Video
Updated: May 21, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Thymic carcinoid associated with multiple endocrine neoplasia type 1]
Itaru Ishida1, Hiroyuki Oura, Hiromichi Niikawa
1Department of Thoracic Surgery, Iwate Prefectural Central Hospital, Morioka, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|June 1, 2012
Summary
This case study highlights a thymic carcinoid linked to Multiple Endocrine Neoplasia type 1 (MEN-1). Surgical intervention for both thymic carcinoid and hyperparathyroidism in MEN-1 patients is effective.
Area of Science:
- Endocrinology
- Thoracic Surgery
- Oncology
Background:
- Multiple Endocrine Neoplasia type 1 (MEN-1) is a genetic disorder predisposing individuals to tumors in endocrine glands.
- Thymic carcinoids are rare neuroendocrine tumors that can be associated with MEN-1.
- Hyperparathyroidism is a common manifestation of MEN-1, often caused by parathyroid adenomas.
Observation:
- A 37-year-old male presented with an anterior mediastinal mass.
- Imaging revealed a 6.5 cm mass, diagnosed as thymic carcinoid via biopsy.
- Endocrinological workup identified pituitary adenoma and hyperparathyroidism, leading to a clinical diagnosis of MEN-1.
Findings:
- Surgical management included thymectomy with lymph node dissection and total parathyroidectomy with autotransplantation.
- Postoperative genomic analysis confirmed the diagnosis of MEN-1.
- The patient's thymic carcinoid and hyperparathyroidism were successfully treated concurrently.
Implications:
- Given that 25% of thymic carcinoids are MEN-1 related and 95% of MEN-1 patients develop hyperparathyroidism, concurrent surgical management is a viable therapeutic strategy.
- This case underscores the importance of considering MEN-1 in patients with thymic carcinoids and vice versa.
- Integrated surgical approaches can improve patient outcomes for complex endocrine-neoplastic syndromes.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...